Revenue: $5,347,190; YoY: -36.64%; QoQ: +78.41%
Gross Profit: $459,635; Gross Margin: 8.60%
Operating Income: -$4,125,095; Operating Margin: -77.15%
EBITDA: -$3,701,414; EBITDA Margin: -69.22%
Net Income: -$4,701,864; Net Margin: -87.93%
EPS (Diluted): -$0.18; Weighted Avg Shares: 26,491,162
Cost of Revenue: $4,887,555; Gross Profit / Revenue: 8.60%
R&D Expenses: $401,826; SG&A: $3,881,274; Selling & Marketing: $196,658
Interest Expense: $572,472; Depreciation & Amortization: $427,978; Other Expenses: $301,630
Net Cash Provided by Operating Activities: -$1,329,688
Free Cash Flow: -$1,360,181
Capex: -$30,493; Cash at End of Period: $116,908; Beginning Cash: $528,281
Total Assets: $39,374,461; Total Liabilities: $35,220,635; Total Stockholders’ Equity: $4,153,826
Total Debt: $18,507,025; Net Debt: $18,390,117
Current Assets: $33,212,669; Current Liabilities: $23,122,097; Cash Ratio: 0.0051; Quick Ratio: 0.0644; Current Ratio: 1.436